These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31148159)

  • 1. Hidradenitis suppurativa and metabolic syndrome - systematic review and adjusted meta-analysis.
    Phan K; Charlton O; Smith SD
    Int J Dermatol; 2019 Oct; 58(10):1112-1117. PubMed ID: 31148159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hidradenitis suppurativa and diabetes mellitus: updated systematic review and adjusted meta-analysis.
    Phan K; Charlton O; Smith SD
    Clin Exp Dermatol; 2019 Jun; 44(4):e126-e132. PubMed ID: 30730068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hidradenitis Suppurativa and Thyroid Disease: Systematic Review and Meta-Analysis.
    Phan K; Huo YR; Charlton O; Smith SD
    J Cutan Med Surg; 2020; 24(1):23-27. PubMed ID: 31994934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Hidradenitis Suppurativa and Metabolic Syndrome: A Systematic Review and Meta-analysis.
    Rodríguez-Zuñiga MJM; García-Perdomo HA; Ortega-Loayza AG
    Actas Dermosifiliogr (Engl Ed); 2019 May; 110(4):279-288. PubMed ID: 30846164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa.
    Gold DA; Reeder VJ; Mahan MG; Hamzavi IH
    J Am Acad Dermatol; 2014 Apr; 70(4):699-703. PubMed ID: 24433875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hidradenitis suppurativa and association with stroke: systematic review and meta-analysis.
    Phan K; Ng WHS; Lai B; Garg A; Smith SD
    J Dermatolog Treat; 2022 Jun; 33(4):2309-2316. PubMed ID: 34289795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of inflammatory bowel disease (IBD) in hidradenitis suppurativa (HS): systematic review and adjusted meta-analysis.
    Phan K; Tatian A; Woods J; Cains G; Frew JW
    Int J Dermatol; 2020 Feb; 59(2):221-228. PubMed ID: 31631340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies.
    Tzellos T; Zouboulis CC; Gulliver W; Cohen AD; Wolkenstein P; Jemec GB
    Br J Dermatol; 2015 Nov; 173(5):1142-55. PubMed ID: 26153913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hidradenitis suppurativa and polycystic ovarian syndrome: Systematic review and meta-analysis.
    Phan K; Charlton O; Smith SD
    Australas J Dermatol; 2020 Feb; 61(1):e28-e33. PubMed ID: 31261440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is hidradenitis suppurativa?
    Lee EY; Alhusayen R; Lansang P; Shear N; Yeung J
    Can Fam Physician; 2017 Feb; 63(2):114-120. PubMed ID: 28209676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Hidradenitis Suppurativa: A Systematic Review and Meta-regression Analysis.
    Jfri A; Nassim D; O'Brien E; Gulliver W; Nikolakis G; Zouboulis CC
    JAMA Dermatol; 2021 Aug; 157(8):924-931. PubMed ID: 34037678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa Foundations.
    Garg A; Malviya N; Strunk A; Wright S; Alavi A; Alhusayen R; Alikhan A; Daveluy SD; Delorme I; Goldfarb N; Gulliver W; Hamzavi I; Jaleel T; Kimball AB; Kirby JS; Kirchhof MG; Lester J; Lev-Tov H; Lowes MA; Micheletti R; Orenstein LA; Piguet V; Sayed C; Tan J; Naik HB
    J Am Acad Dermatol; 2022 May; 86(5):1092-1101. PubMed ID: 33493574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of psoriasis in people with hidradenitis suppurativa: A systematic review and meta-analysis.
    Gau SY; Preclaro IAC; Wei JC; Lee CY; Kuan YH; Hsiao YP; Juang SE; Ma KS
    Front Immunol; 2022; 13():1033844. PubMed ID: 36532043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of metabolic syndrome and hidradenitis suppurativa.
    Miller IM; Ellervik C; Vinding GR; Zarchi K; Ibler KS; Knudsen KM; Jemec GB
    JAMA Dermatol; 2014 Dec; 150(12):1273-80. PubMed ID: 25229996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa.
    Zouboulis CC; Desai N; Emtestam L; Hunger RE; Ioannides D; Juhász I; Lapins J; Matusiak L; Prens EP; Revuz J; Schneider-Burrus S; Szepietowski JC; van der Zee HH; Jemec GB
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):619-44. PubMed ID: 25640693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?
    Karagiannidis I; Nikolakis G; Sabat R; Zouboulis CC
    Rev Endocr Metab Disord; 2016 Sep; 17(3):335-341. PubMed ID: 27294593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of liver dysfunction and non-alcoholic fatty liver diseases in people with hidradenitis suppurativa: A systematic review and meta-analysis of real-world evidences.
    Gau SY; Hsiao YP; Liao WC; Ma KS; Wu MC
    Front Immunol; 2022; 13():959691. PubMed ID: 36591267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Hidradenitis Suppurativa in Patients with Inflammatory Bowel Disease.
    Lukach AJ; Saul MI; Ferris LK; Swoger JM
    Dig Dis Sci; 2018 Mar; 63(3):755-760. PubMed ID: 29357084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hidradenitis suppurativa - Management, comorbidities and monitoring.
    Vekic DA; Cains GD
    Aust Fam Physician; 2017; 46(8):584-588. PubMed ID: 28787558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence and odds of anxiety and depression in children and adults with hidradenitis suppurativa: Systematic review and meta-analysis.
    Jalenques I; Ciortianu L; Pereira B; D'Incan M; Lauron S; Rondepierre F
    J Am Acad Dermatol; 2020 Aug; 83(2):542-553. PubMed ID: 32222447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.